Electroneum (ETN) has risen 114% over the last 7 days on news that its Instant Payment API for vendors is now open and in Beta, making integration of cryptocurrency payments..
Thomas Cook Group (LON:TCG) today announced pre closing trading update. · Good strategic progress through the year to date · Challenging period of ‘lates’ trading following unprecedented months of hot..
SSE Plc (LON:SSE) noted that Total is today announcing a major gas discovery on the Glendronach prospect, which is located in the Greater Laggan Area, West of Shetland. The Glendronach..
Randgold Resources Limited (LON:RRS) and the boards of Barrick Gold Corporation today announced that they have reached agreement on the terms of a recommended share-for-share merger of Barrick and Randgold..
AstraZeneca Plc (LON:AZN) announced today positive results from the Phase III DECLARE-TIMI 58 cardiovascular (CV) outcomes trial (CVOT) for Farxiga (dapagliflozin), the broadest SGLT2 inhibitor CVOT conducted to date. The..
Oncimmune Holdings plc (LON:ONC), a leader in the development, manufacture and marketing of personalised immunodiagnostics for the screening, detection and care of cancer, announced today that it has appointed Adam..
Nasstar plc (LON:NASA), a provider of hosted managed and cloud computing services, announced today its unaudited interim results for the 6 months ended 30 June 2018. Financial Highlights · Revenue..
Deltex Medical Group plc (LON:DEMG), the global leader in oesophageal doppler monitoring has today announced its results for the six-month period ended 30 June 2018. Operational highlights * Andy Mears..
Ceres Power Holdings plc (LON: CWR) confirms that, further to the announcement on 21 August 2018, 5,973,660 new ordinary shares of 10 pence each have been allotted to Robert Bosch..
Warpaint London plc (LON:W7L), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands, announced today the implementation of a new Long-Term Incentive Plan with initial..
4D pharma plc (LON:DDDD), a pharmaceutical company leading the development of live biotherapeutics, today announced positive top-line results for its Phase Ib study of Thetanix in paediatric patients with Crohn’s..
